Therapies for dopaminergic-induced dyskinesias in parkinson disease
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapies for dopaminergic-induced dyskinesias in parkinson disease
Authors
Keywords
-
Journal
ANNALS OF NEUROLOGY
Volume 69, Issue 6, Pages 919-927
Publisher
Wiley
Online
2011-03-17
DOI
10.1002/ana.22423
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Preladenant in patients with Parkinson's disease and motor fluctuations: a phase 2, double-blind, randomised trial
- (2011) Robert A Hauser et al. LANCET NEUROLOGY
- Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: The STRIDE-PD study
- (2010) Fabrizio Stocchi et al. ANNALS OF NEUROLOGY
- Continuous dopaminergic therapy in Parkinson disease: Time to stride back?
- (2010) A. Jon Stoessl ANNALS OF NEUROLOGY
- Double-blind study of pardoprunox, a new partial dopamine agonist, in early Parkinson's disease
- (2010) Juliana Bronzova et al. MOVEMENT DISORDERS
- Task force report on scales to assess dyskinesia in Parkinson's disease: Critique and recommendations
- (2010) Carlo Colosimo et al. MOVEMENT DISORDERS
- Long-term antidyskinetic efficacy of amantadine in Parkinson's disease
- (2010) Elisabeth Wolf et al. MOVEMENT DISORDERS
- Age of Parkinson's disease onset as a predictor for the development of dyskinesia
- (2010) Stephen Ku et al. MOVEMENT DISORDERS
- Onset of dyskinesia with adjunct ropinirole prolonged-release or additional levodopa in early Parkinson's disease
- (2010) Ray L. Watts et al. MOVEMENT DISORDERS
- Dyskinesia and the antiparkinsonian response always temporally coincide: A retrospective study
- (2010) J. G. Nutt et al. NEUROLOGY
- Long-term Effect of Initiating Pramipexole vs Levodopa in Early Parkinson Disease
- (2009) ARCHIVES OF NEUROLOGY
- Multiple roles for nicotine in Parkinson's disease
- (2009) Maryka Quik et al. BIOCHEMICAL PHARMACOLOGY
- Continuous Jejunal Levodopa Infusion in Patients With Advanced Parkinson Disease
- (2009) Karla Eggert et al. CLINICAL NEUROPHARMACOLOGY
- Safety and Tolerability of Pardoprunox, a New Partial Dopamine Agonist, in a Randomized, Controlled Study of Patients with Advanced Parkinson’s Disease
- (2009) R.A. Hauser et al. EUROPEAN NEUROLOGY
- Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's disease
- (2009) David Devos et al. MOVEMENT DISORDERS
- Pros and cons of apomorphine and l-dopa continuous infusion in advanced Parkinson's disease
- (2009) Angelo Antonini et al. PARKINSONISM & RELATED DISORDERS
- Molecular mechanisms underlying levodopa-induced dyskinesia
- (2008) Paolo Calabresi et al. MOVEMENT DISORDERS
- Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: A multicenter study
- (2008) Pedro J. García Ruiz et al. MOVEMENT DISORDERS
- Nicotine and Parkinson's disease: Implications for therapy
- (2008) Maryka Quik et al. MOVEMENT DISORDERS
- Molecular mechanisms of L-DOPA-induced dyskinesia
- (2008) Peter Jenner NATURE REVIEWS NEUROSCIENCE
- Priming for l-dopa-induced dyskinesia in Parkinson’s disease: A feature inherent to the treatment or the disease?
- (2008) Agnès Nadjar et al. PROGRESS IN NEUROBIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started